A detailed history of Firethorn Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Firethorn Wealth Partners, LLC holds 2,832 shares of ABBV stock, worth $536,522. This represents 0.3% of its overall portfolio holdings.

Number of Shares
2,832
Previous 2,655 6.67%
Holding current value
$536,522
Previous $455,000 22.86%
% of portfolio
0.3%
Previous 0.27%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $28,999 - $35,281
177 Added 6.67%
2,832 $559,000
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $27,862 - $32,536
180 Added 7.27%
2,655 $455,000
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $1,118 - $1,274
-7 Reduced 0.28%
2,475 $450,000
Q4 2023

Jan 25, 2024

BUY
$137.6 - $154.97 $76,092 - $85,698
553 Added 28.67%
2,482 $384,000
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $6,946 - $8,041
52 Added 2.77%
1,929 $287,000
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $1,060 - $1,319
8 Added 0.43%
1,877 $252,000
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $65,652 - $75,609
-454 Reduced 19.54%
1,869 $297,000
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $1,521 - $1,824
11 Added 0.48%
2,323 $375,000
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $52,744 - $60,494
-393 Reduced 14.53%
2,312 $310,000
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $8,532 - $10,847
62 Added 2.35%
2,705 $379,000
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $1,583 - $1,965
12 Added 0.46%
2,643 $429,000
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $60,697 - $76,800
565 Added 27.35%
2,631 $356,000
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $1,788 - $1,992
17 Added 0.83%
2,066 $233,000
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $9,616 - $10,586
94 Added 4.81%
2,049 $222,000
Q4 2020

Mar 09, 2021

BUY
$80.49 - $108.67 $157,357 - $212,449
1,955 New
1,955 $209,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Firethorn Wealth Partners, LLC Portfolio

Follow Firethorn Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firethorn Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Firethorn Wealth Partners, LLC with notifications on news.